Overview

Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases

Status:
Terminated

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The primary purpose of the study is to evaluate if motexafin gadolinium with whole brain radiation therapy followed by a stereotactic radiosurgery boost is a safe and effective treatment.

Phase:

Phase 2

Details

Lead Sponsor:

Pharmacyclics LLC.

Treatments:

Motexafin gadolinium